NSC-41589 is primarily used in research settings to study its potential as an anticancer agent. It has been investigated for its ability to inhibit the growth of cancer cells, particularly in experimental models of leukemia and other malignancies. Researchers explore its mechanism of action to understand how it interacts with cellular pathways, such as DNA replication or cell cycle regulation, to induce apoptosis or halt tumor progression. Additionally, NSC-41589 is utilized in preclinical studies to evaluate its efficacy, toxicity, and pharmacokinetics, providing insights for the development of novel therapeutic compounds. Its application is largely confined to laboratory studies, contributing to the advancement of cancer drug discovery.